None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All persons who got admitted in Quarantine center of 20 to 60 years willing to participate, with or without co-morbid condition with exposure/chance of exposure to COVID 19 positive cases. 2. Who are willing to provide signed informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating females. 2. Known case of Carcinoma lungs, CRF and CHF. 3. Participants with any immunosuppressive medication or in an immune compromised state or hematological disease. 4. Laboratory confirmed COVID-19 with or without symptoms. 5. DM uncontrolled with medications. 6. Any other criteria, as per the investigator would jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of participants with SARS- Cov-2 positivity and Number/ percentage of participants not developing any Covid-19 like sign & symptoms (Time line 30 days)Timepoint: Percentage of participants with SARS- Cov-2 positivity and Number/ percentage of participants not developing any Covid-19 like sign & symptoms (Time line 30 days) | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety profile of the intervention as estimated by LFT, KFT and other hematological & biochemical investigations. (Time frame: 30 days) 1. Presence or absence of AE/ADR and their level of tolerability 2. Number of participants who developed any infective diseases during the trial period (bacterial /viral/ fungal / etc.) and percentage of participants with Upper respiratory tract illness during the period.Timepoint: 30 days | — |
Countries
India
Contacts
Dr SR Rajasthan Ayurveda University,Jodhpur(Raj.)